Stating the obvious here, but ...
What this deal means us that
- the value or even potential value in DXB200 is not purely speculative but its biotech value has been assessed based on on technical/industry grounds. Of course will carry some matket speculative element to it.
- this is partial value in lieu of a US agreement.
- this deal will put more serious emphasis/attention on DXB700 and DXBxxx.
DXB Chart, page-285
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.025(5.62%) |
Mkt cap ! $261.8M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 49.5¢ | 45.0¢ | $2.042M | 4.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 98853 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |